Stock Information
Travere Therapeutics Inc (TVTX)
Ticker Symbol: TVTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $4,075.36 mil
Piotroski score: 7
PE Ratio: N/A
EPS (TTM): -0.3293
Revenue (TTM): $5.43 M
Dividend Yield: N/A%
ROE: -40.24%
Latest News
-
Travere Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Thu, May 7, 2026 7:30 PM
-
Travere Therapeutics to Participate at Upcoming Investor Conferences
Thu, May 7, 2026 4:31 PM
-
Travere Prices Upsized $475.0 Million Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
Wed, May 6, 2026 10:29 PM
-
Wells Fargo Maintains Overweight on Travere Therapeutics, Raises Price Target to $50
Wed, May 6, 2026 9:29 AM
-
Travere Therapeutics Plans To Offer $400M Senior Convertible Notes Due 2032
Tue, May 5, 2026 4:26 PM
-
Travere Announces Proposed Convertible Senior Notes Offering to Refinance 2029 Convertible Notes
Tue, May 5, 2026 4:02 PM
-
Travere Therapeutics Analysts Increase Their Forecasts Following Q1 Earnings
Tue, May 5, 2026 2:41 PM
-
TD Cowen Maintains Buy on Travere Therapeutics, Raises Price Target to $60
Tue, May 5, 2026 1:38 PM
-
Citigroup Maintains Buy on Travere Therapeutics, Raises Price Target to $59
Tue, May 5, 2026 11:56 AM
-
Wedbush Maintains Outperform on Travere Therapeutics, Raises Price Target to $55
Tue, May 5, 2026 9:29 AM
Key Financials
Financial data not available
